Literature DB >> 4117700

Androstenediol levels in human peripheral plasma.

R L Rosenfield, P Otto.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4117700     DOI: 10.1210/jcem-35-6-818

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  6 in total

1.  Persistent testicular delta5-isomerase-3beta-hydroxysteroid dehydrogenase (delta5-3beta-HSD) deficiency in the delta5-3beta-HSD form of congenital adrenal hyperplasia.

Authors:  G Schneider; M Genel; A M Bongiovanni; A S Goldman; R L Rosenfield
Journal:  J Clin Invest       Date:  1975-04       Impact factor: 14.808

2.  Testosterone-estradiol-binding globulin, unbound and total estradiol and testosterone, and total progesterone during the menstrual cycle in women with epilepsy taking antiepileptic drugs.

Authors:  C T Bäckström; R Södergård
Journal:  J Endocrinol Invest       Date:  1979 Oct-Dec       Impact factor: 4.256

3.  Androstenedione and androst-5-ene-3 beta,17 beta-diol stimulate DMBA-induced rat mammary tumors--role of aromatase.

Authors:  S Dauvois; F Labrie
Journal:  Breast Cancer Res Treat       Date:  1989-01       Impact factor: 4.872

4.  Adrenal steroids stimulate growth and progesterone receptor levels in rat uterus and DMBA-induced mammary tumors.

Authors:  P G Spinola; B Marchetti; F Labrie
Journal:  Breast Cancer Res Treat       Date:  1986       Impact factor: 4.872

5.  Multiple Genetic Associations with Irish Wolfhound Dilated Cardiomyopathy.

Authors:  Siobhan Simpson; Mark D Dunning; Serena Brownlie; Janika Patel; Megan Godden; Malcolm Cobb; Nigel P Mongan; Catrin S Rutland
Journal:  Biomed Res Int       Date:  2016-12-13       Impact factor: 3.411

6.  5-En-androstene-3 beta,17 beta-diol inhibits the growth of MCF-7 breast cancer cells when oestrogen receptors are blocked by oestradiol.

Authors:  G Boccuzzi; E Brignardello; M Di Monaco; V Gatto; L Leonardi; A Pizzini; M Gallo
Journal:  Br J Cancer       Date:  1994-12       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.